AI digest — Oct 29, 2026
Top line: US election campaigns are now adopting generative engine optimization — tactics aimed at getting a candidate's position to surface inside AI chatbot answers, a shift that raises reliability-of-information questions days before Election Day. Anthropic reports research work with six medicine-developing organizations and its own first drug-discovery efforts. And a viral anecdote endorsed by Elon Musk shows a Grok Bot shopping around an Amazon block: locked out of Amazon, the bot bought the same product from another site at a lower price.
1. US election campaigns turn to GEO — optimizing for chatbot answers
What happened: Candidates in US elections are adopting campaign tactics aimed at AI chatbots rather than only at search rankings — a strategy the report calls GEO (Generative Engine Optimization), described in the headline as moving "beyond top search rankings to securing a place in AI answers." As more voters take answers from chatbots, the outlet reports the competition is spreading into the US election season and raising questions about the reliability of information voters receive.
What's genuinely new: First report in today's coverage of domestic US election campaigns actively deploying GEO tactics to influence what AI chatbots say about candidates — a campaign-tool frame that goes beyond the state-directed retrieval-layer influence operations reported in September and early October, and distinct from platform- or lab-side election preparations.
Watch: Which campaigns are named and what specific tactics they used; whether the chatbot platforms (OpenAI, Anthropic, xAI, Google) publish election-related answers policies before Election Day on November 3, 2026; whether any regulator or election authority picks up the information-reliability question.
Sources Economy.ac
2. Anthropic reports six drug-development research partnerships and its own drug-discovery start
What happened: Anthropic says that over the past few months its scientists have engaged in deep research partnerships with six organizations developing new medicines, and that it has begun drug-discovery efforts of its own. The company published a blog post with what it calls early results and an account of how Claude can support the many stages of drug development.
What's genuinely new: A specific count of research partnerships — six medicine-focused organizations — named for the first time, plus Anthropic's first stated move into its own internal drug discovery, rather than guest-authored or externally run science claims.
Watch: Whether the six partner organizations are named and one is independently confirmed; whether any "early result" survives the pattern of the thread so far, where company-graded science claims (enzyme system, quantum circuits, scorpion-toxin binders) have drawn heavyweight press checks but not independent validation.
Sources Anthropic (research post) Anthropic announcement (via Elon Musk repost)
3. A Grok Bot routes around an Amazon block — and buys the product cheaper elsewhere
Thread: ai — Agent-harness race: OpenClaw 2.0 and xAI Grok Build · continuing
What happened: A user posted that Amazon locked out his Grok Bot, so the bot bought the same product from a different site at a lower price. Elon Musk amplified the anecdote on October 28 at about 10:30 PM ET, replying "That's what I do too. Just have @Bot buy it somewhere else at a lower price."
What's genuinely new: The first public consumer-side anecdote of an agent responding to a platform's access block by autonomously re-routing the purchase to an alternative merchant — a concrete turn in the platform-vs-agent commerce fight that has run since Amazon's October 15 move to block unauthorized consumer agents.
Watch: Whether Amazon responds publicly to agent routing and whether it extends blocks to alternative merchants; whether anecdote becomes a pattern or platform-side design friction (the residential-address leak was one earlier friction datapoint); whether other users document bypass purchases independently.
Sources Elon Musk (X) User anecdote (X)
Brief
- Neuralink's own account says early speech-restoration data in ALS participants shows speech-to-text and voice at conversational rates — one participant reached 75 words per minute at a 5.8% word error rate on a 125,000-word vocabulary in their first week; Thrive Capital's Dr. Nworah Ayogu called the problems Neuralink is solving "almost biblical in proportion." Company self-report; no independent clinical coverage yet. (Neuralink (X) · sourcery via Musk RT (X))
- OpenClaw says four of its developers made the Linux Foundation's Top 100 contributors list — first, seventh, 33rd and 57th — with 569,649 contributions in a year, 13.8% of the Top 100 total. (OpenClaw (X))
- On Microsoft's earnings call, CEO Satya Nadella said Microsoft Cloud revenue surpassed $63 billion with growth accelerating to 30% year over year, framed around building for what he calls the agentic wave. (Satya Nadella via Musk RT (X))